A. Wynne

发表

Preconditioning the diabetic human myocardium

D. Yellon, D. Hausenloy, V. Sivaraman, 2009, Journal of cellular and molecular medicine.

Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced Protection

M. Duchen, D. Yellon, D. Hausenloy, 2004, Circulation.

The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat

R. Dixon, D. Yellon, S. Davidson, 2009, Journal of cardiovascular pharmacology.

Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects

D. Yellon, A. Wynne, J. C. Simpkin, 2006, British journal of pharmacology.

Temporal Changes in Myocardial Salvage Kinases During Reperfusion Following Ischemia: Studies Involving the Cardioprotective Adipocytokine Apelin

R. Dixon, D. Yellon, Michaela M. Mocanu, 2007, Cardiovascular Drugs and Therapy.

Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury

M. Mocanu, D. Yellon, S. Davidson, 2011, Journal of cardiovascular pharmacology and therapeutics.

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury

D. Yellon, S. Davidson, Shiang Y. Lim, 2007, Basic Research in Cardiology.

Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.

R. Dixon, D. Yellon, S. Davidson, 2010, American journal of physiology. Heart and circulatory physiology.

Does the mitochondrial permeability transition have a role in preconditioning? Response

M. Duchen, D. Yellon, D. Hausenloy, 2004 .

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

G. Bhamra, M. Mocanu, D. Yellon, 2008, Basic Research in Cardiology.

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner

M. Mocanu, D. Yellon, D. Hausenloy, 2013, Cardiovascular Diabetology.

Ischemic preconditioning targets the reperfusion phase

D. Yellon, D. Hausenloy, D. Yellon, 2007, Basic Research in Cardiology.

FC1 Dipeptidyl peptidase IV inhibitors limit myocardial infarct size in a glucose-sensitive manner

M. Mocanu, D. Hausenloy, D. Yellon, 2010, Heart.

Pioglitazone Mimics Preconditioning in the Isolated Perfused Rat Heart: A Role for the Prosurvival Kinases PI3K and P42/44MAPK

M. Mocanu, D. Yellon, A. Wynne, 2005, Journal of cardiovascular pharmacology.

Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart

M. Mocanu, D. Yellon, D. Hausenloy, 2013, Journal of cardiovascular pharmacology and therapeutics.

Apelin exhibits cardioprotection against ischaemia reperfusion injury

S. Davidson, D. Yellon, A. Wynne, 2007 .